Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...

ALEX Neil was disappointed to have to make early substitutions during Millwall's 2-0 loss to Leeds United on Wednesday, and ...

StockNews.com started coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s ...

Ali Al-Hamadi's return to scoring form against Blackburn Rovers could provide a huge boost to both loan side Stoke City, as ...

Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Aquestive Therapeutics in a ...

Stoke City goalkeeper Viktor Johansson has been praised by manager Mark Robins for the way he bounced back from a difficult ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2024 financial results on Thursday, March 20, ...

Millwall have picked up just five points in their six league games at the Den under Alex Neil (W1 D2 L3), scoring just five goals in that time from 65 shots (7.7% conversion rate).

Wexford-based biopharmaceutical company Coeptis Inc. announced the formation of GEAR Therapeutics, a majority-owned ...

Follow live coverage as Stoke City face Blackburn Rovers in the Championship today. An increasingly competitive second tier ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...